Sánchez-Ramos Evelyn L, Monárrez-Espino Joel, Noyola Daniel E
Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico.
Karolinska Institutet, Stockholm, Sweden.
Vaccine. 2017 Mar 1;35(9):1287-1292. doi: 10.1016/j.vaccine.2017.01.038. Epub 2017 Feb 2.
Influenza is a leading cause of respiratory tract infections among children. In Mexico, influenza vaccination was included in the National Immunization Program since 2004. However, the population health effects of the vaccine on children have not been fully described. Thus, we estimated the impact of influenza immunization in terms of mortality associated with this virus among children younger than 5years of age in Mexico.
Mortality rates and years of life lost associated with influenza were estimated using national mortality register data for the period 1998-2012. Age-stratified and cause-specific mortality rates were estimated for all-cause, respiratory and cardiovascular events. Influenza-associated mortality was compared between the period prior to introduction of the influenza vaccine as part of the National Immunization Program (1998-2004) and the period thereafter (2004-2012).
During the 1998-2012 winter seasons, the average number of all-cause, respiratory and cardiovascular deaths attributable to influenza were 1186, 794 and 21, respectively. Influenza-associated mortality was higher prior to the vaccination period than after influenza was included in the immunization program for all-cause (mean 1660 vs. 780) and respiratory (mean 1063 vs. 563) mortality, but no reduction was seen for cardiovascular mortality. The proportion of all-cause and respiratory deaths attributable to influenza was significantly lower in the post-vaccine period compared with the pre-vaccine period (P<0.001), but no reduction was seen in the proportion of cardiovascular deaths. There was an average annual reduction of 66,558years of life lost in the post-vaccine compared with the pre-vaccine period.
The introduction of influenza vaccination within the Mexican Immunization Program was associated with a reduction in mortality rates attributable to this virus among children younger than 5years of age.
流感是儿童呼吸道感染的主要原因。在墨西哥,自2004年起流感疫苗接种被纳入国家免疫规划。然而,该疫苗对儿童人群健康的影响尚未得到充分描述。因此,我们估计了流感免疫接种对墨西哥5岁以下儿童中与该病毒相关死亡率的影响。
利用1998 - 2012年期间的国家死亡率登记数据,估计与流感相关的死亡率和寿命损失年数。估计了全因、呼吸道和心血管事件的年龄分层及特定病因死亡率。比较了作为国家免疫规划一部分引入流感疫苗之前(1998 - 2004年)和之后(2004 - 2012年)与流感相关的死亡率。
在1998 - 2012年冬季季节,归因于流感的全因、呼吸道和心血管死亡的平均数量分别为1186例、794例和21例。在疫苗接种期之前,与流感相关的死亡率高于流感被纳入免疫规划之后,全因死亡率(平均1660例对780例)和呼吸道死亡率(平均1063例对563例)均是如此,但心血管死亡率未见降低。与疫苗接种前相比,疫苗接种后归因于流感的全因和呼吸道死亡比例显著降低(P<0.001),但心血管死亡比例未见降低。与疫苗接种前相比,疫苗接种后平均每年减少寿命损失66558年。
墨西哥免疫规划中引入流感疫苗接种与5岁以下儿童中该病毒所致死亡率降低相关。